AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

TEKCAPITAL PLC

Regulatory Filings Mar 2, 2017

7955_rns_2017-03-02_4e3fe458-ac2c-4c1a-a884-b7c92738b33a.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2739Y

Tekcapital plc

02 March 2017

2 March 2017

Tekcapital plc

("Tekcapital" or the "Company")

BELLUSCURA LTD LAUNCHES SLYDE™ IN EU

Tekcapital plc (AIM: TEK), an international provider of technology and intellectual property services, announces that Belluscura Ltd ("Belluscura") has launched its Slyde product in the European Union.

Slyde is a light and compact sled for moving its occupant safely down stairs or over rough ground in the event of an emergency evacuation.  It provides a safe and efficient way to evacuate non-ambulatory individuals from any multi-storey building using the stairways. Slyde folds up and stores in stacks of up to five units in a storage sleeve. The sleeve can be wall-mounted for quick access in key locations.  Slyde is sold in two sizes with a range of accessories designed to safely lower people in the event of an emergency evacuation.

Stephen Appelbee, Belluscura's International Director of Global Sales said:

"We are delighted to make this important step towards becoming a truly international medical device company.  Our first product, Slyde, is a good example of Belluscura's mission to provide premium medical device products at affordable prices, and we expect it to be widely adopted by hospitals, schools, hotels and rescue services.  We intend to use the expertise of local distributors in each region, starting in the European Union."

Slyde is already available and selling in the USA.

About Belluscura:

Belluscura Limited is a global medical device company founded in Oxford, England.  Its mission is to make healthcare more affordable for patients and their providers by providing proprietary medical devices across a wide variety of treatment and diagnostic disciplines.  Belluscura's products were originally developed by leading medical device companies or research centres, and with its unique business model it is able to offer these devices at affordable prices. To learn more about Belluscura please visit www.belluscura.com.

Tekcapital owns approximately 65% of the share capital of Belluscura.

For further information, please contact:

Tekcapital Plc
Clifford M. Gross, Ph.D. [email protected]
Allenby Capital Limited (Nominated Adviser & Joint Broker) +44 (0) 20 3328 5656
Jeremy Porter / Alex Brearley
Dowgate Capital Stockbrokers (Joint Broker) +44 (0) 1293 517744
David Poutney / James Serjeant
Walbrook PR Ltd +44 (0) 20 7933 8780
Paul Cornelius / Helen Cresswell / Sam Allen [email protected]

Tekcapital plc - The World's Largest University Network for Open Innovation

Tekcapital helps clients profit from new, university-developed intellectual properties. With its proprietary discovery search engine, linked to 4,500+ universities in 160 countries, coupled with expert scientific review, Tekcapital provides a turn-key service to make it easy for clients to find and acquire the IP, analytics and technology transfer professionals they need to create a competitive advantage. Tekcapital plc is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

LEI: 213800GOJTOV19FIFZ85

http://www.rns-pdf.londonstockexchange.com/rns/2739Y_-2017-3-1.pdf

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRAEAKDFEALXEFF

Talk to a Data Expert

Have a question? We'll get back to you promptly.